The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells
Author:
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.4161/onci.23991
Reference27 articles.
1. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
2. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
3. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function
4. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
5. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies;Cancers;2023-05-05
2. Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab;Journal for ImmunoTherapy of Cancer;2023-05
3. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer;Journal for ImmunoTherapy of Cancer;2022-12
4. Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV;Frontiers in Oncology;2022-11-22
5. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells;Journal for ImmunoTherapy of Cancer;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3